Literature DB >> 15202618

Renoprotection by enzyme replacement therapy.

Barry M Brenner1, Jean-Pierre Grünfeld.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15202618     DOI： 10.1097/00041552-200403000-00012

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN： 1062-4821            Impact factor:   2.894


× No keyword cloud information.
  6 in total

1.  Schiffmann R, Rapkiewicz A, Abu-Asab M, Ries M, Askari H, Tsokos M, Quezado M. Pathological findings in a patient with Fabry disease, who died after 2.5 years of enzyme replacement. Virchows Arch. 2005 Nov 29; 1-7.

Authors:  Juan Politei
Journal:  Virchows Arch       Date:  2006-03-08       Impact factor: 4.064

Review 2.  Agalsidase Beta: a review of its use in the management of Fabry disease.

Authors:  Gillian M Keating; Dene Simpson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Non-invasive high-risk screening for Fabry disease hemizygotes and heterozygotes.

Authors:  Teruo Kitagawa; Ken Suzuki; Nobuyuki Ishige; Toya Ohashi; Masahisa Kobayashi; Yoshikatsu Eto; Akemi Tanaka; Hideo Odaka; Misao Owada
Journal:  Pediatr Nephrol       Date:  2008-06-06       Impact factor: 3.714

4.  Serum globotriaosylceramide assay as a screening test for fabry disease in patients with ESRD on maintenance dialysis in Korea.

Authors:  Jeong-Yup Kim; Young-Youl Hyun; Ji-Eun Lee; Hye-Ran Yoon; Gu-Hwan Kim; Han-Wook Yoo; Seong-Tae Cho; No-Won Chun; Byoung-Chunn Jeoung; Hwa-Jung Kim; Keong-Wook Kim; Seong-Nam Kim; Yung-A Kim; Hyun-Ah Lee; Jong-Young Lee; Yung-Chun Lee; Hun-Kwan Lim; Keong-Sik Oh; Seong-Hwan Son; Beong-Hee Yu; Kyeong-So Wee; Eun-Jong Lee; Young-Ki Lee; Jung-Woo Noh; Seung-Jung Kim; Kyu-Bok Choi; Suk-Hee Yu; Heui-Jung Pyo; Young-Joo Kwon
Journal:  Korean J Intern Med       Date:  2010-11-27       Impact factor: 3.165

5.  Replacement of alpha-galactosidase A in Fabry disease: effect on fibroblast cultures compared with biopsied tissues of treated patients.

Authors:  Jana Keslová-Veselíková; Helena Hůlková; Robert Dobrovolný; Befekadu Asfaw; Helena Poupetová; Linda Berná; Jakub Sikora; Lubor Golán; Jana Ledvinová; Milan Elleder
Journal:  Virchows Arch       Date:  2008-03-20       Impact factor: 4.064

6.  Fabry cardiomyopathy.

Authors:  Jae Yong Yoon; Joon Hyuk Song; Sang Soo Cheon; Hyun Jun Cho; Myung Hwan Bae; Jang Hoon Lee; Dong Heon Yang; Hun Sik Park; Yongkeun Cho; Shung Chull Chae
Journal:  J Cardiovasc Ultrasound       Date:  2013-03-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.